跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 474 条关于
“Raynaud's phenomenon”
全部
474
临床试验
272
药物
3
机构
0
资讯
199
上个月
Liquidia's YUTREPIA Receives FDA Fast Track Designation for Systemic Sclerosis-Associated Raynaud's Phenomenon
6个月前
Aisa Pharma's AISA-021 Shows Promise in Phase 2 Trial for Systemic Sclerosis-Associated Raynaud's Phenomenon
8个月前
Liquidia Reports Strong YUTREPIA Launch with $148.3M in Full-Year 2025 Sales, Expands Clinical Pipeline
去年
FDA Approves First CGRP Antagonist for Pediatric Migraine Prevention as Ajovy Expands to Children
9天前
AbbVie's Atogepant Hits Primary and All Eight Secondary Endpoints in Phase III Menstrual Migraine Trial
上个月
COVID-19 Shifts to a Summer Phenomenon as Cases Rise Across the US
3个月前
PDE4B Emerges as Shared Therapeutic Target Across Tissues in Systemic Sclerosis
2个月前
UK Government Issues Supply Warnings for Nifedipine and Oxcarbazepine Amid Multiple Brand Shortages
去年
End-of-Dose Phenomena Observed in Multiple Sclerosis Patients on Ofatumumab
8天前
Immunotherapy, Not Chemotherapy, Drives Hair Repigmentation in Thoracic Cancer Patients
第 1 页,共 20 页
上一页
下一页